Volume 24, Number 1—January 2018
Characterization of a Feline Influenza A(H7N2) Virus
Highlight and copy the desired format.
|EID||Hatta M, Zhong G, Gao Y, Nakajima N, Fan S, Chiba S, et al. Characterization of a Feline Influenza A(H7N2) Virus. Emerg Infect Dis. 2018;24(1):75-86. https://dx.doi.org/10.3201/eid2401.171240|
|AMA||Hatta M, Zhong G, Gao Y, et al. Characterization of a Feline Influenza A(H7N2) Virus. Emerging Infectious Diseases. 2018;24(1):75-86. doi:10.3201/eid2401.171240.|
|APA||Hatta, M., Zhong, G., Gao, Y., Nakajima, N., Fan, S., Chiba, S....Kawaoka, Y. (2018). Characterization of a Feline Influenza A(H7N2) Virus. Emerging Infectious Diseases, 24(1), 75-86. https://dx.doi.org/10.3201/eid2401.171240.|
During December 2016–February 2017, influenza A viruses of the H7N2 subtype infected ≈500 cats in animal shelters in New York, NY, USA, indicating virus transmission among cats. A veterinarian who treated the animals also became infected with feline influenza A(H7N2) virus and experienced respiratory symptoms. To understand the pathogenicity and transmissibility of these feline H7N2 viruses in mammals, we characterized them in vitro and in vivo. Feline H7N2 subtype viruses replicated in the respiratory organs of mice, ferrets, and cats without causing severe lesions. Direct contact transmission of feline H7N2 subtype viruses was detected in ferrets and cats; in cats, exposed animals were also infected via respiratory droplet transmission. These results suggest that the feline H7N2 subtype viruses could spread among cats and also infect humans. Outbreaks of the feline H7N2 viruses could, therefore, pose a risk to public health.
Influenza A viruses are endemic in humans and enzootic in other mammalian species including swine and horses; occasional infections of other mammalian species including whales, seals, sea lions, felidae in zoos, and other species have been reported (1). Reports of influenza A virus infections in dogs and cats were rare until 2004, when equine influenza viruses of the H3N8 subtype caused outbreaks in greyhounds in Florida (2). Since then, influenza viruses of the H3N8 and H3N2 subtypes have caused several outbreaks in dogs in the United States and South Korea (3–5).
Until recently, only 1 major influenza A virus outbreak had been reported in cats (6). This changed in December 2016 with the outbreak of low pathogenic avian influenza A viruses of the H7N2 subtype in animal shelters in New York. Approximately 500 cats were infected in December 2016–February 2017; most of which experienced a mild illness with coughing, sneezing, and runny nose from which they recovered fully. Severe pneumonia developed in 1 elderly animal with underlying health issues, which was euthanized. A veterinarian who had treated an infected animal also became infected with the feline influenza A(H7N2) virus and experienced a mild, transient illness, suggesting the potential for these viruses to infect humans. While this manuscript was being prepared, Belser et al. reported that the H7N2 subtype virus isolated from the human case caused a mild disease in mice and ferrets, but was not transmitted among ferrets (7). We assessed feline H7N2 subtype viruses isolated from infected cats during the outbreak for their replicative ability, pathogenicity, and transmissibility in mammals; in contrast to the findings recently published by Belser et al. (7), we detected productive infection of co-housed ferrets, although with low efficiency. We also conducted extensive pathology and transmission studies in cats, and detected feline virus transmission via respiratory droplets to exposed cats. Our study provides additional data on the risk that the feline H7N2 subtype viruses pose to public health.
Cells and Viruses
The origins and growth conditions of all cell lines used in this study are described in the Technical Appendix [PDF - 3.63 MB - 35 pages]. The feline H7N2 subtype viruses used in this study were isolated from swabs collected from cats with influenza-like symptoms during the outbreak in an animal shelter in New York in December 2016. We obtained A/chicken/New York/22409–4/1999 (H7N2, A/chicken/NY/99) virus from the Agricultural Research Service, US Department of Agriculture (8). We deposited the viral gene sequences obtained in this study to GenBank. We amplified the feline virus in Madin-Darby canine kidney (MDCK) cells and the A/chicken/NY/99 virus in 10-day-old embryonated chicken eggs.
Growth Kinetics of Viruses in Cell Culture
We infected cells with viruses at a 0.005 multiplicity of infection, incubated them for 1 hour at 37°C, washed twice, and cultured with 1× minimal essential medium containing 0.3% bovine serum albumin and trypsin treated with L-1-tosylamide-2-phenylethyl chloromethyl ketone at 33°C and 37°C (37°C and 39°C for chicken embryo fibroblast cells) for various periods. We determined virus titers at the indicated time points by use of plaque assays in MDCK cells. The statistical analyses are described in the Technical Appendix [PDF - 3.63 MB - 35 pages].
Infection of Animals
To determine the pathogenicity of the viruses in infected mice, we anesthetized three 6-week-old female BALB/c mice (Jackson Laboratory, Bar Harbor, ME, USA) for each virus with isoflurane and inoculated intranasally with 10-fold serially diluted virus in a 50-µL volume. The mice were monitored daily for 14 days and checked for changes in body weight and morbidity and mortality. We euthanized animals if they lost more than 25% of their initial bodyweight.
To determine the pathogenicity of the viruses in infected ferrets and cats, we inoculated 6-month-old female ferrets (Triple F Farms, Sayre, PA, USA; 3 per group; serologically negative by hemagglutination inhibition assay for currently circulating human influenza viruses), and unvaccinated 4- to 5-month-old female specific-pathogen-free cats (Liberty Research, Waverly, NY, USA; 3 per group) intranasally with 106 PFU of viruses in 0.5 ml of phosphate-buffered saline. We monitored the animals daily for changes in bodyweight, body temperature, and clinical signs for 14 days.
For virus replication in organs and pathology analyses, we worked with groups of mice (12 per group), ferrets (6 per group), and cats (6 per group).We inoculated the animals intranasally with 105 PFU (mice) in 0.05 ml of phosphate-buffered saline or 106 PFU (ferrets and cats) of viruses in 0.5 ml of phosphate-buffered saline. On days 3 and 6 postinfection, we euthanized 6 mice, 3 ferrets, and 3 cats in each group for pathological analysis and virus titration in organs (by use of plaque assays in MDCK cells).
Virus Transmission Studies in Ferrets and Cats
For direct contact transmission experiments, we housed 3 ferrets per group in regular ferret cages and 3 cats per group in large dog transporter cages (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 1), and infected them intranasally with 106 PFU (500 μL) of viruses. One day later, we housed 1 virus-naive animal with each infected animal. We collected nasal washes from the infected ferrets and nasal swabs from the infected cats on day 1 after infection, and from the exposed animals on day 1 after exposure and then every other day (for up to 11 days). We determined virus titers in the nasal washes and swabs by performing plaque assays in MDCK cells. We monitored all animals daily for disease symptoms and changes in bodyweight and temperature for 14 days.
We performed airborne transmission experiments by using ferret isolators (Showa Science, Tokyo, Japan) (9–11) or regular cat cages. In these settings, there was no directional airflow from the infected to the exposed animals. We inoculated 3 animals per group intranasally with 106 PFU (500 μL) of viruses. One day after infection, we placed 3 immunologically naive animals (exposed animals) each in a cage adjacent to an infected animal. This setting prevented direct and indirect contact between animals but allowed spread of influenza virus by respiratory droplet. We spaced the ferret cages 5 cm apart and the cat cages 35 cm apart. We monitored the animals and assessed virus titers as described above.
Genetic and Phylogenetic Analysis of Feline Influenza(H7N2) Viruses Isolated in Animal Shelters in New York, December 2016
We obtained swabs (collected on the same day) from 5 cats that experienced influenza-like symptoms during the outbreak at an animal shelter in New York, NY, in December 2016. After inoculation of these samples into MDCK cells, we isolated 5 pleomorphic influenza A viruses of the H7N2 subtype (Table 1; Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 2). The HA consensus sequences of the 5 isolates (established by Sanger sequence analysis) displayed >99.9% similarity at the nucleotide level (Table 1). Phylogenetic analyses demonstrated that the 8 viral RNA segments of the 5 feline H7N2 viruses are most closely related to poultry influenza A(H7N2) viruses detected in the New York area in the late 1990s through early 2000s (Figure 1; Technical Appendix [PDF - 3.63 MB - 35 pages] Figures 3–9), suggesting that the 2016 feline H7N2 virus isolates descended from viruses that circulated more than a decade ago in the northeastern United States.
The HA protein of the 2016 feline H7N2 subtype virus encodes a single arginine residue at the hemagglutinin cleavage site (PEKPKPR↓G; the arrow indicates the cleavage site that creates the HA1 and HA2 subunits), indicative of low pathogenicity in chickens. Antigenically, A/feline/New York/WVDL-14/2016 (A/feline/NY/16) differs from other, closely related H7 viruses (Technical Appendix [PDF - 3.63 MB - 35 pages] Table 1); for example, its HA deviates by 27 aa from the closely related A/chicken/NY/22409–4/1999 HA. The neuraminidase (NA) and ion channel (M2) proteins of the H7N2 viruses do not encode amino acids that confer resistance to neuraminidase or ion channel inhibitors. Inspection of the remaining feline H7N2 viral proteins revealed an absence of the most prominent amino acid changes known to facilitate adaptation to mammals, such as PB2–627K (16). These data thus suggest the 2016 feline H7N2 subtype viruses are avian-derived influenza viruses of low pathogenicity in avian and mammalian species.
Replication of Feline and Avian H7N2 Subtype Viruses in Cultured Cells
To characterize the replicative ability of the 2016 feline H7N2 viruses in cultured cells, we compared A/feline/NY/16 (which encodes the consensus amino acid sequence of the 5 isolates) with a closely related 1999 avian influenza virus, A/chicken/NY/22409–4/1999 (H7N2, A/chicken/NY/99) (Figure 1 and Technical Appendix [PDF - 3.63 MB - 35 pages] Figures 3–9), which was isolated from a chicken in a live-bird market in New York state in 1999 (8). There are a total of 97 aa differences between A/feline/NY/16 and A/chicken/NY/99 viruses (12 aa differences in polymerase basic 2 (PB2), 7 in polymerase basic 1 (PB1), 12 in polymerase acidic (PA), 27 in hemagglutinin (HA), 8 in nucleoprotein (NP), 11 in neuraminidase (NA), 7 in matrix protein 1 (M1), 4 in matrix protein 2 (M2), and 9 in nonstructural protein 1 (NS1). Canine, human, feline, and chicken cells were infected at a multiplicity of infection of 0.005 at temperatures mimicking those of the upper and lower respiratory tract of the respective species (i.e., 37°C and 39°C for chicken cells; 33°C and 37°C for the remaining cells) (Figure 2). In canine MDCK, feline Clone81, and human Calu-3 cells, A/feline/NY/16 replicated at least as efficiently as A/chicken/NY/99 virus, while both viruses replicated to low titers in human A549 cells. Of note, A/feline/NY/16 virus replicated less efficiently than A/chicken/NY/99 virus in feline lung Fc2Lu cells. In chicken embryo fibroblast cells, A/feline/NY/16 virus replicated more slowly than A/chicken/NY/99 virus at early time points and reached its highest titers at later time points. When we compared virus growth at the 2 temperatures tested (i.e., 37°C and 39°C for chicken cells; 33°C and 37°C for the remaining cells), we observed similar trends (for example, in MDCK cells, A/feline/NY/16 replicated more efficiently than A/chicken/NY/99 at both temperatures tested).
Replication and Pathogenicity of Feline and Avian H7N2 Subtype Viruses in Mice
To assess the replication of A/feline/NY/16 and A/chicken/NY/99 viruses in mice, 3 mice per group were inoculated intranasally with 10-fold dilutions of viruses, and their bodyweight and morbidity and mortality were monitored daily for 14 days. Mice infected with A/feline/NY/16 virus did not experience weight loss or signs of disease, whereas infection with 106 PFU of A/chicken/NY/99 virus caused severe weight loss and required euthanasia (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 10).
A/feline/NY/16 replicated efficiently in the nasal turbinates and less efficiently in the lungs of infected animals (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 11); no virus was isolated from the other organs tested (i.e., brains, kidneys, livers, and spleens; data not shown). A/chicken/NY/99 replicated more efficiently in the lungs than in the nasal turbinates, consistent with immunohistochemistry analyses that detected A/feline/NY/16 virus antigens mainly in the upper respiratory organs of infected mice, whereas A/chicken/NY/99 virus antigens were detected more frequently in the lower respiratory organs (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 12).
Replication and Pathogenicity of Feline and Avian H7N2 Subtype Viruses in Ferrets
Ferrets intranasally infected with 106 PFU of A/feline/NY/16 or A/chicken/NY/99 virus did not lose bodyweight (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 13) but 2 of the ferrets infected with A/chicken/NY/99 virus had high fevers on day 1 postinfection. Both viruses replicated efficiently in the nasal turbinates and were also isolated from the trachea and lungs of some animals (Table 2), consistent with similar antigen distributions for both viruses (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 14). No viruses were isolated from any of the other organs tested.
Replication and Pathogenicity of Feline and Avian H7N2 Subtype Viruses in Cats
The infection of ≈500 cats with H7N2 subtype viruses in animal shelters in New York in December 2016 suggested efficient replication of these viruses in felines. However, it was unclear whether these viruses were restricted to the respiratory organs or caused systemic infection. Cats intranasally infected with 106 PFU of A/feline/NY/16 or A/chicken/NY/99 did not lose bodyweight (Figure 3); however, fever was detected in 1 animal infected with A/feline/NY/16, and 1 infected with A/chicken/NY/99 virus; and a different animal infected with A/feline/NY/16 sneezed intensely on day 3 postinfection, but recovered fully.
A/feline/NY/16 virus replicated efficiently in the nasal turbinates, trachea, and lungs of infected cats (with the exception of 1 cat with a virus-negative lung sample on day 3 postinfection; Table 2). We isolated A/chicken/NY/99 virus mostly from nasal turbinates, with limited replication in the trachea and lung. These findings are consistent with the detection of A/feline/NY/16 antigen in both the upper and lower respiratory organs of infected cats, whereas A/chicken/NY/99 antigen was detected mainly in the nasal turbinates (Figure 4). A/feline/NY/16 and A/chicken/NY/99 viruses were also isolated from the jejunum or colon of some of the infected animals (Table 2), although viral antigen was not detected in the intestines of cats infected with A/chicken/NY/99 or A/feline/NY/16 virus. These results demonstrate that the feline H7N2 virus replicates efficiently in the upper and lower respiratory tract of cats, reflecting adaptation of the virus to its new host.
All cats infected with the A/feline/NY/16 virus exhibited histologic lesions in their nasal turbinates, tracheas, and lungs. Nasal turbinate pathology was moderate to severe in 5 of 6 cats with multifocal to diffuse distribution of lesions (Figure 5, panel A). The tracheas of these cats exhibited mild to moderate histopathology (Figure 5, panel B), whereas the lungs exhibited multifocal to coalescing histopathology centered mostly on the bronchioles, with 3 of 6 cats possessing moderately severe lesions (Figure 5, panel C). Similar histopathological changes were found in cats infected with A/chicken/NY/99 virus. Appreciable histopathology was also noted in the small intestine (duodenum) of cats infected with A/feline/NY/16 and A/chicken/NY/99 viruses (Figure 5, panel D; cat ID nos. 1, 2, 4, 8, 10, and 12 in Table 2), although virus was detected in the intestines of only 3 cats (cat ID nos. 4, 6, and 9 in Table 2). The correlation between virus replication and histologic lesions in cat intestines is currently unknown.
Transmission of Feline and Avian H7N2 Subtype Viruses in Ferrets and Cats
The fulminant spread of the feline H7N2 subtype viruses among cats, and the confirmed H7N2 virus infection of a veterinarian who treated the animals, indicate that these originally avian influenza viruses have the ability to transmit among mammals. To test the transmissibility of feline and avian H7N2 subtype viruses in ferrets, 3 animals per group (each placed in a separate cage) were infected intranasally with 106 PFU (500 μL) of A/feline/NY/16 or A/chicken/NY/99 virus. One day later, we housed 1 naive ferret with each of the infected ferrets (direct contact transmission experiment), or placed naive ferrets in wireframe cages (within transmission isolators) ≈5 cm from the cages containing the infected ferrets as a respiratory droplet transmission experiment. We collected nasal wash samples from infected, contact, and exposed animals on day 1 after infection, contact, or exposure, and then every other day; we determined virus titers in nasal wash samples by use of plaque assays in MDCK cells (Table 3). In respiratory droplet transmission experiments, ferrets infected with A/feline/NY/16 or A/chicken/NY/99 virus secreted virus, but exposed animals were virus negative and did not seroconvert (Table 3). Among the direct contact animals, we detected virus in 1 ferret from the A/feline/NY/16-inoculated group and 2 from the A/chicken/NY/99-inoculated group; these 3 animals seroconverted, although the HI titer of 1 of the animals was low.
We conducted the transmission study in cats in the same way as the study in ferrets; we spaced cages 35 cm apart to prevent direct contact between the inoculated and exposed animals (Technical Appendix [PDF - 3.63 MB - 35 pages] Figure 1, panel A). All infected cats secreted viruses for 5–7 days after infection and seroconverted, except for 1 cat infected with A/chicken/NY/99 virus, which seroconverted but did not shed virus (Table 4). We did not isolate A/chicken/NY/99 virus from contact or exposed animals, although these animals seroconverted (Table 4). Direct contact transmission of A/feline/NY/16 virus was detected in all 3 pairs of cats, with both seroconversion and virus isolation in 2 pairs (Table 4). Respiratory droplet transmission of A/feline/NY/16 occurred in 2 pairs of animals, with high virus titers detected in the nasal secretions of the exposed animals on days 9 and 11 postexposure, respectively; both of the exposed animals also seroconverted (Table 4). In the third transmission pair, the exposed animal did not shed virus or seroconvert. Taken together, we demonstrated that A/feline/NY/16 virus has the ability to transmit among cats via contact and respiratory droplets; the relative contribution of these modes of transmission to the H7N2 subtype virus outbreaks in cat shelters in New York is unknown.
Receptor-Binding Specificity of Feline and Avian H7N2 Subtype Viruses
Avian influenza viruses isolated from their natural reservoir (i.e., wild aquatic birds) are often restricted in their ability to infect mammalian cells because of their preferential binding to α2,3-linked sialic acids, whereas most human influenza viruses preferentially bind to α2,6-linked sialic acids (17–19). We performed glycan array analysis with A/feline/NY/16, A/chicken/NY/99, and Kawasaki/173-PR8, a control virus possessing the HA and NA genes of the seasonal human A/Kawasaki/173/2001 (H1N1) virus and the remaining genes from A/PR/8/34 (H1N1) virus. As expected, Kawasaki/173-PR8 virus bound to α2,6-linked sialosides (Figure 6; Technical Appendix [PDF - 3.63 MB - 35 pages] Table 2). A/chicken/NY/99 virus bound to both α2,6- and α2,3-linked sialosides, consistent with the dual avian/human receptor-binding specificity of influenza viruses isolated from land-based poultry (1). Of note, A/feline/NY/16 virus bound strongly to α2,3-linked sialosides (i.e., avian-type receptors) with negligible binding to human-type receptors.
Next, we examined the prevalence of α2,3- and α2,6-linked sialosides in the feline airway and intestines of an immunologically naive cat by using lectins that detect α2,3-linked (i.e., MAA I and MAA II) and α2,6-linked sialosides (i.e., SNAI). MAA I and MAIA II bound to epithelial cells throughout the feline airway, whereas SNA binding was detected only in the trachea and bronchus (Figure 7), consistent with the findings of other research groups (20–22). We did not detect sialosides in the cat intestine. The predominance of avian-type receptors in the upper respiratory tract of felines may have led to the selection of feline H7N2 virus HA proteins with preferential binding to α2,3-linked sialosides.
Sensitivity to Neuraminidase Inhibitors
To test whether infections with the feline H7N2 viruses could be treated with neuraminidase (NA) inhibitors, we assessed the sensitivity of A/feline/NY/16 and A/chicken/NY/99 to several NA inhibitors (i.e., oseltamivir, zanamivir, and laninamivir) by determining the 50% inhibitory concentration (IC50) of the NA enzymatic activity. We used A/Anhui/1/2013 (H7N9) virus as an NA inhibitor–sensitive control and its NA inhibitor–resistant variant, A/Anhui/1/2013-NA-R294K, as an NA inhibitor–resistant control (Technical Appendix [PDF - 3.63 MB - 35 pages] Table 3). A/feline/NY/16 and A/chicken/NY/99 were sensitive to all of the NA inhibitors tested (Technical Appendix [PDF - 3.63 MB - 35 pages] Table 3), consistent with the absence of amino acid residues in the NA protein that are known to confer resistance to NA inhibitors. Hence, NA inhibitors could be used to treat persons infected with feline H7N2 subtype viruses.
In our study, we demonstrated that a feline H7N2 subtype virus isolated during an outbreak in an animal shelter in New York in December 2016 replicated well in the respiratory organs of mice and ferrets but did not cause severe symptoms. The efficient replication of the feline H7N2 subtype viruses in the respiratory organs of several mammals, combined with the ability of these viruses to transmit among cats (albeit inefficiently) and to infect 1 person, suggest that these viruses could pose a risk to human health. Close contacts between humans and their pets could lead to the transmission of the feline viruses to humans. To protect public health, shelter animals (where stress and limited space may facilitate virus spread) should be monitored closely for potential outbreaks of influenza viruses.
Our findings of mild disease in mice and ferrets are consistent with the recent report by Belser et al. (7) who studied the H7N2 subtype virus isolated from an infected veterinarian. We also assessed feline H7N2 virulence in cats and detected efficient virus replication in both the upper and lower respiratory organs of infected animals, whereas an avian H7N2 subtype virus was detected mainly in the nasal turbinates.
Belser et al. (7) reported that intranasal or aerosol infection of ferrets with the H7N2 virus isolated from the infected veterinarian did not result in the seroconversion of co-housed or exposed animals, although nasal wash samples from some of the co-housed ferrets contained low titers of virus; these findings may suggest limited virus transmission that was insufficient to establish a productive infection. In contrast, we detected feline H7N2 virus transmission to co-housed ferrets in 1 of 3 pairs tested; this difference may be explained by the amino acid differences in the PA, HA, and NA proteins of the feline and human H7N2 isolates (Technical Appendix [PDF - 3.63 MB - 35 pages] Table 4) or by the small number of animals used in these studies. We also performed transmission studies in cats and detected feline H7N2 subtype virus transmission via direct contact and respiratory droplets. However, the group size used is a potential limitation of our study.
Cats are not a major reservoir of influenza A viruses, but can be infected naturally or experimentally with influenza viruses of different subtypes (23). Serologic surveys suggest high and low rates of seroconversion to seasonal human and highly pathogenic avian influenza viruses, respectively. Natural infections most likely result from close contact with infected humans or animals, and most of these infections appear to be self-limiting.
Few cases of human infections with influenza viruses of the H7 subtype were reported until 2013, and they typically caused mild illness; however, infection of a veterinarian with a highly pathogenic avian H7N7 virus had fatal consequences (24,25). Since 2013, influenza viruses of the H7N9 subtype have caused more than 1,300 laboratory-confirmed infections in humans, with a case-fatality rate of ≈30%. Although the current H7N9 and feline H7N2 subtype viruses do not exclusively bind to human-type receptors and do not transmit efficiently among humans, the spread and biologic properties of these viruses should be monitored carefully.
Dr. Hatta is a senior scientist at the Influenza Research Institute at the University of Wisconsin–Madison, Madison, WI. His research focuses on identifying the molecular determinants of influenza virus pathogenicity, with particular emphasis on the pathogenicity of highly pathogenic influenza viruses.
We thank Susan Watson for scientific editing; Peter J. Jester, Alexander Karasin, Kelly E. Moore, Zachary Najacht, Erin M. Plisch, Robert G. Presler, and Backiyalakshmi Ammayappan Venkatachalam for technical assistance; and Philip N. Bochsler for training personnel for animal dissections. We also thank personnel from the Research Animal Resources Center and the Charmany Instructional Facility, University of Wisconsin–Madison, for animal care and technical support.
This work was supported by the NIAID-funded Center for Research on Influenza Pathogenesis (CRIP, HHSN272201400008C) to Y.K.; by NIH grant AI114730 to J.C.P.; by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) to Y.K.; by Leading Advanced Projects for medical innovation (LEAP) from AMED to Y.K.; and by Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan (Nos. 16H06429, 16K21723, and 16H06434) to Y.K.
- Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, et al., editors. Fields Virology. Sixth ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2013. p. 1186–243.
- Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, et al. Transmission of equine influenza virus to dogs. Science. 2005;310:482–5.
- Xie X, Ma K, Liu Y. Influenza A virus infection in dogs: epizootiology, evolution and prevention - A review. Acta Vet Hung. 2016;64:125–39.
- Song D, Kang B, Lee C, Jung K, Ha G, Kang D, et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis. 2008;14:741–6.
- Lee YN, Lee DH, Lee HJ, Park JK, Yuk SS, Sung HJ, et al. Evidence of H3N2 canine influenza virus infection before 2007. Vet Rec. 2012;171:477.
- Fiorentini L, Taddei R, Moreno A, Gelmetti D, Barbieri I, De Marco MA, et al. Influenza A pandemic (H1N1) 2009 virus outbreak in a cat colony in Italy. Zoonoses Public Health. 2011;58:573–81.
- Belser JA, Pulit-Penaloza JA, Sun X, Brock N, Pappas C, Creager HM, et al. A novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model. J Virol. 2017;91:e00672–17.
- Spackman E, Senne DA, Davison S, Suarez DL. Sequence analysis of recent H7 avian influenza viruses associated with three different outbreaks in commercial poultry in the United States. J Virol. 2003;77:13399–402.
- Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486:420–8.
- Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013;501:551–5.
- Arafa AS, Yamada S, Imai M, Watanabe T, Yamayoshi S, Iwatsuki-Horimoto K, et al. Risk assessment of recent Egyptian H5N1 influenza viruses. Sci Rep. 2016;6:38388.
- Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–25.
- Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39:783–91.
- Tamura K. Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases. Mol Biol Evol. 1992;9:678–87.
- Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.
- Centers for Disease Control and Prevention. H5N1 genetic changes inventory:
- a tool for influenza surveillance and preparedness. 2012 [cited 2017 Jul 27]. https://www.cdc.gov/flu/pdf/avianflu/h5n1-inventory.pdf
- Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology. 1994;205:17–23.
- Gambaryan AS, Tuzikov AB, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, et al. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology. 1997;232:345–50.
- Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, et al. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology. 1997;233:224–34.
- Wang H, Wu X, Cheng Y, An Y, Ning Z. Tissue distribution of human and avian type sialic acid influenza virus receptors in domestic cat. Acta Vet Hung. 2013;61:537–46.
- Said AW, Usui T, Shinya K, Ono E, Ito T, Hikasa Y, et al. A Sero-survey of subtype H3 influenza a virus infection in dogs and cats in Japan. J Vet Med Sci. 2011;73:541–4.
- Thongratsakul S, Suzuki Y, Hiramatsu H, Sakpuaram T, Sirinarumitr T, Poolkhet C, et al. Avian and human influenza A virus receptors in trachea and lung of animals. Asian Pac J Allergy Immunol. 2010;28:294–301.
- Harder TC, Vahlenkamp TW. Influenza virus infections in dogs and cats. Vet Immunol Immunopathol. 2010;134:54–60.
- Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004;101:1356–61.
- Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587–93.
- Figure 1. Phylogenetic tree of influenza A viral HA segments. Phylogenetic analysis was performed for selected influenza A viruses representing major lineages. The evolutionary history was inferred using the neighbor-joining method...
- Figure 2. Growth properties of A/feline/NY/16 and A/chicken/NY/99 viruses in mammalian and avian cells at different temperatures. Cells were infected with viruses at a multiplicity of infection of 0.005 and incubated...
- Figure 3. Body weight and temperature changes in cats infected with A/feline/NY/16 and A/chicken/NY/99 viruses. Three cats per group were infected intranasally with 106 PFU of viruses and monitored for bodyweight...
- Figure 4. Immunohistochemistry findings in infected cats. Shown are representative sections of nasal turbinates and lungs of cats infected with the indicated viruses on days 3 and 6 postinfection. Three cats...
- Figure 5. Pathology findings in cats infected with A/feline/NY/16 influenza A(H7N2) virus on day 6 postinfection, New York, NY, USA. A) In lungs, moderately severe histopathologic changes are present in the...
- Figure 6. Receptor-binding specificities of influenza A viruses, New York, NY, USA. A) A representative human virus, A/Kawasaki/ 173-PR8(H1N1) is shown for comparison with B) the avian influenza A(H7N2) virus A/chicken/NY/99...
- Figure 7. Distribution of α2,3- and α2,6-linked sialosides in the respiratory organs of a cat, New York, NY, USA. The α2,3- and α2,6-linked sialosides in the respiratory organs of a naïve...
- Table 1. Amino acid differences among feline H7N2 virus isolates
- Table 2. Virus titers in organs of ferrets and cats infected with A/feline/NY/16 or A/chicken/NY/99 influenza viruses
- Table 3. Virus titers in nasal wash samples from ferret transmission studies
- Table 4. Virus titers in nasal swab samples from cat transmission studies
- Technical Appendix. Additional information from the study of feline influenza A(H7N2) virus isolated in New York. 3.63 MB
1These authors contributed equally to this article.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Yoshihiro Kawaoka, Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin–Madison, 575 Science Dr, Madison, WI 53711, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 19, 2017
- Page last updated: December 19, 2017
- Page last reviewed: December 19, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)